News

7 months ago

Final results for the year ended 31 December 2023

7 months ago

ProteoGenix and Cizzle Biotechnology Collaboration Forges New Paths in Early Detection of Lung Cancer through Innovative Antibody Development

8 months ago

Strategic Licensing and Partnership Memorandum of Understanding for North America

8 months ago

Placing to raise £0.62 million and Appointment of Joint Broker

1 year ago

Cizzle Biotechnology programme with US firm Bio-Techne takes major step forward (Interview)

2 years ago

Considerable progress in first year since listing

3 years ago

Cizzle Biotechnology to offer early lung cancer tech throughout the USA (Interview)

3 years ago

Final results due end-April

3 years ago

Hardman Research : Strategic alliance in China

3 years ago

Cizzle Biotechnology to take early lung cancer test to £3b China market (Interview)